Mostrar el registro sencillo del ítem
Alpha-synuclein repeat variants and survival in parkinson's disease
dc.creator | Chung, S. J. | en |
dc.creator | Biernacka, J. M. | en |
dc.creator | Armasu, S. M. | en |
dc.creator | Anderson, K. | en |
dc.creator | Frigerio, R. | en |
dc.creator | Aasly, J. O. | en |
dc.creator | Annesi, G. | en |
dc.creator | Bentivoglio, A. R. | en |
dc.creator | Brighina, L. | en |
dc.creator | Chartier-Harlin, M. C. | en |
dc.creator | Goldwurm, S. | en |
dc.creator | Hadjigeorgiou, G. | en |
dc.creator | Jasinska-Myga, B. | en |
dc.creator | Jeon, B. S. | en |
dc.creator | Kim, Y. J. | en |
dc.creator | Krüger, R. | en |
dc.creator | Lesage, S. | en |
dc.creator | Markopoulou, K. | en |
dc.creator | Mellick, G. | en |
dc.creator | Morrison, K. E. | en |
dc.creator | Puschmann, A. | en |
dc.creator | Tan, E. K. | en |
dc.creator | Crosiers, D. | en |
dc.creator | Theuns, J. | en |
dc.creator | Van Broeckhoven, C. | en |
dc.creator | Wirdefeldt, K. | en |
dc.creator | Wszolek, Z. K. | en |
dc.creator | Elbaz, A. | en |
dc.creator | Maraganore, D. M. | en |
dc.creator | Yahalom, G. | en |
dc.creator | Orlev, Y. | en |
dc.creator | Cohen, O. S. | en |
dc.creator | Kozlova, E. | en |
dc.creator | Friedman, E. | en |
dc.creator | Inzelberg, R. | en |
dc.creator | Hassin-Baer, S. | en |
dc.date.accessioned | 2015-11-23T10:24:48Z | |
dc.date.available | 2015-11-23T10:24:48Z | |
dc.date.issued | 2014 | |
dc.identifier | 10.1002/mds.25841 | |
dc.identifier.issn | 8853185 | |
dc.identifier.uri | http://hdl.handle.net/11615/26727 | |
dc.description.abstract | Objectives: To determine whether α-synuclein dinucleotide repeat (REP1) genotypes are associated with survival in Parkinson's disease (PD). Methods: Investigators from the Genetic Epidemiology of Parkinson's Disease Consortium provided REP1 genotypes and baseline and follow-up clinical data for cases. The primary outcome was time to death. Cox proportional hazards regression models were used to assess the association of REP1 genotypes with survival. Results: Twenty-one sites contributed data for 6,154 cases. There was no significant association between α-synuclein REP1 genotypes and survival in PD. However, there was a significant association between REP1 genotypes and age at onset of PD (hazard ratio: 1.06; 95% confidence interval: 1.01-1.10; P value=0.01). Conclusions: In our large consortium study, α-synuclein REP1 genotypes were not associated with survival in PD. Further studies of α-synuclein's role in disease progression and long-term outcomes are needed. © 2014 International Parkinson and Movement Disorder Society. | en |
dc.source.uri | http://www.scopus.com/inward/record.url?eid=2-s2.0-84904431856&partnerID=40&md5=30a48d7e05bddf3db94f2e62c7c16665 | |
dc.subject | Association | en |
dc.subject | Gene | en |
dc.subject | Parkinson's disease | en |
dc.subject | Survival | en |
dc.subject | α-synuclein | en |
dc.subject | alpha synuclein | en |
dc.subject | adult | en |
dc.subject | aged | en |
dc.subject | clinical trial | en |
dc.subject | dinucleotide repeat | en |
dc.subject | female | en |
dc.subject | gene frequency | en |
dc.subject | genetic association | en |
dc.subject | genetic predisposition | en |
dc.subject | genetics | en |
dc.subject | genotype | en |
dc.subject | human | en |
dc.subject | international cooperation | en |
dc.subject | male | en |
dc.subject | middle aged | en |
dc.subject | mortality | en |
dc.subject | multicenter study | en |
dc.subject | onset age | en |
dc.subject | Parkinson disease | en |
dc.subject | very elderly | en |
dc.subject | Age of Onset | en |
dc.subject | Aged, 80 and over | en |
dc.subject | alpha-Synuclein | en |
dc.subject | Dinucleotide Repeats | en |
dc.subject | Genetic Association Studies | en |
dc.subject | Genetic Predisposition to Disease | en |
dc.subject | Humans | en |
dc.title | Alpha-synuclein repeat variants and survival in parkinson's disease | en |
dc.type | journalArticle | en |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |